CRO

A Fresh Look to a Familiar Face: Meet the New WCG

WCG has supported the clinical trial space for a long time – 55 years, to be exact. Our founding members pioneered the concept of Independent Ethical Review in 1968, almost a decade before it was federally mandated for human research. But clinical trials don't end at ethical review. It's just the beginning. Which is why we’ve become a family of companies providing best-in-class clinical solutions across the clinical trial journey.

Those involved in clinical trials have a long road to study closeout that’s often riddled with challenges, from enrollment and retention to site identification and endpoint data quality. It has always been WCG’s mission to address these critical inflection points, paving the way for clients to accelerate the development of new life-saving medical therapies to those who need them most. We’ve done this through strategic acquisitions and organic growth resulting in unmatched domain expertise.

We’re proud of our history and the pivotal role we have to play in the advancement of clinical research. Now we’re turning the page on an exciting new chapter in our story with the announcement of WCG’s revitalized brand identity, representing the unification of WCG to optimize value delivery and innovation to our clients.

We’ve transformed from the inside out to streamline efficiencies in how we serve our clients at scale, bringing our many legacy companies together as simply “WCG” – an enabler and true partner whose unrivaled knowledge, highly specialized solutions, and data-driven insights touched 95% percent of all FDA-approved therapeutic agents last year.

Our teams have worked long and hard to deeply infuse this change organization-wide. Our new look and feel reflect our most authentic identity as an industry leader, providing the connectivity, data intelligence, and expertise required to successfully advance clinical research. Our new brand identity can be viewed in its entirety at www.wcgclinical.com.

We help our clients do what they do best, better.

WCG’s unique connectivity throughout the clinical trial ecosystem enables sponsors, CROs, sites, and trial participants to effectively collaborate in navigating increasingly complex protocol requirements.

Whether you’re a sponsor looking to protect participants with expert review of safety and efficacy data, a CRO needing to streamline multi-vendor relationships, a research site looking to efficiently recruit and engage diverse participant populations, or a participant looking for a trial opportunity, WCG will connect you to the crucial resources you need.

WCG delivers insights to help clients make informed decisions with confidence.

WCG leverages the power of data intelligence to enable clinical trial success. Because we’re so deeply connected throughout the clinical trial ecosystem, our proprietary data intelligence and predictive analytics allow clients to detect meaningful patterns, from recruitment trends and historical site performance to data anomalies and potential safety issues. Insights inform decision-making and support optimal diversity of participants, so that studies accurately reflect patient populations.

WCG’s deep domain expertise helps accelerate the development of life-changing therapies by improving the conduct and quality of clinical trials.

WCG has acquired incredible domain expertise over the years and today offers 1,500+ curated experts covering all therapeutic areas with 30+ tech-enabled, data-driven, expert-guided solutions. Our 1700+ strong global workforce supports trials in 130+ countries. You can learn more about WCG’s leadership here.

The industry’s best managed study review, bar none.

Study review is how our story began, and we continue to lead the way as an undisputed global leader in this area. From Institutional Review Boards (IRBs) and Institutional Biosafety Committees (IBCs) to Endpoint Adjudication Committees (EACs) and Data Monitoring Committees (DMCs), WCG set the bar (quite literally with the creation of the world’s first commercial IRB 55 years ago) and has been raising it ever since.

Here's to another 55+ years!

Since the beginning, WCG has remained steadfast in our commitment to expand access, and enhance the quality, efficiency, and safety required to successfully advance research. We’ve accumulated incredible domain expertise, evolving into the trusted partner for 95 percent of all FDA-approved therapeutic agents.

Our journey has been one filled with inspiration, innovation, passion, integrity, and resilience. We are deeply grateful to every person who has ventured alongside us. We’re thrilled to introduce the new WCG that elevates our visual identity and most accurately captures our mission to improve lives by accelerating research, together.

The editorial staff had no role in this post's creation.